FY2024 Earnings Forecast for The Cooper Companies, Inc. Issued By Zacks Research (NASDAQ:COO)

The Cooper Companies, Inc. (NASDAQ:COO) – Analysts at Zacks Research raised their FY2024 earnings per share (EPS) estimates for shares of Cooper Companies in a research report issued on Wednesday, September 18th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical device company will earn $3.64 per share for the year, up from their prior estimate of $3.55. The consensus estimate for Cooper Companies’ current full-year earnings is $3.66 per share. Zacks Research also issued estimates for Cooper Companies’ Q4 2024 earnings at $0.98 EPS, Q1 2025 earnings at $0.92 EPS, Q3 2025 earnings at $1.04 EPS, Q4 2025 earnings at $1.07 EPS, FY2025 earnings at $3.97 EPS, Q1 2026 earnings at $1.01 EPS, Q2 2026 earnings at $1.05 EPS, Q3 2026 earnings at $1.13 EPS and FY2026 earnings at $4.36 EPS.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period in the previous year, the firm posted $0.84 EPS. Cooper Companies’s revenue was up 7.8% on a year-over-year basis.

Several other equities analysts have also weighed in on COO. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Robert W. Baird increased their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Stifel Nicolaus restated a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Wells Fargo & Company increased their price target on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $115.00.

Cooper Companies Stock Performance

Shares of COO stock opened at $110.49 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The firm has a market capitalization of $22.00 billion, a price-to-earnings ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98. Cooper Companies has a one year low of $75.93 and a one year high of $112.38. The company has a 50 day moving average price of $97.93 and a 200 day moving average price of $95.54.

Insiders Place Their Bets

In related news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares in the company, valued at approximately $4,714,534.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock valued at $27,637,427 over the last quarter. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Cooper Companies

Institutional investors have recently bought and sold shares of the stock. Benjamin F. Edwards & Company Inc. lifted its position in Cooper Companies by 248.6% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock worth $25,000 after purchasing an additional 174 shares during the period. Brown Brothers Harriman & Co. lifted its holdings in shares of Cooper Companies by 412.2% in the fourth quarter. Brown Brothers Harriman & Co. now owns 251 shares of the medical device company’s stock valued at $95,000 after buying an additional 202 shares during the period. Covestor Ltd boosted its stake in Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after buying an additional 208 shares in the last quarter. Innealta Capital LLC acquired a new position in Cooper Companies during the second quarter worth about $25,000. Finally, Crewe Advisors LLC raised its position in Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after acquiring an additional 252 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.